Skip to main content
letter
. 2020 Jan 9;105(10):e507–e511. doi: 10.3324/haematol.2019.229260

Figure 1.

Figure 1.

Cumulative incidence of relapse according to leukemia initiating cell burden. (A) according to the GPR56 expression at diagnosis, high vs. low, median cut; (B) according to the CD34+/CD38– cell burden at diagnosis, high vs. low, 6% cut; (C) according to the CD34+/CD38–cell burden and the GPR56 expression.